Search Results 111-120 of 14779 for anti-TNF drugs

1. Developing Antidrug Antibodies to Infliximab or Adalimumab in HLA DQ Alleles - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... Developing Antidrug Antibodies to Infliximab or Adalimumab in HLA DQ Alleles ... Previously received a positive ...

2. A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors - Mayo Clinic

   A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary ...

3. Publications - Lynne S. Peterson, M.D. - Mayo Clinic

   ... anti-TNF therapy (poster presentation). European League Against Rheumatism (EULAR).2004;; Peterson LS, Mason T, Mason T, Nelson AM, O'Fallon WM, Gabriel SE ...

4. A Study to Evaluate the Effectiveness and Safety of Triple Combination Therapy in High Risk Crohn's Disease (CD) - Mayo Clinic

   ... anti-integrin (vedolizumab intravenous [IV]), a tumor necrosis factor (TNF) antagonist (adalimumab subcutaneously [SC]), and an immunomodulator (oral ...

5. Pain medicines after surgery - Mayo Clinic

   Other medicines that can treat pain after surgery include the anti-anxiety medicine midazolam and the anti-seizure medicines gabapentin (Gralise, Horizant, ...

6. Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects with Moderate to Severe Crohn's Disease - Mayo Clinic

   This study will evaluate the efficacy and safety of two adalimumab induction regimens in subjects with moderately to severely active Crohn's disease and ...

7. The microbiome, fecal microbiota transplants and inflammatory bowel disease - Mayo Clinic

   Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD · Article. Research establishes strong association between ...

8. How obesity affects IBD management and patient outcomes: Q&A with Amanda M. Johnson, M.D. - Mayo Clinic

   Related Content. Article. Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD · Article. Research establishes ...

9. Publications - Laura E. Raffals, M.D. - Mayo Clinic

   Anti-TNF biologic therapy does not increase postoperative morbidity in pediatric Crohn's patients. J Pediatr Surg. 2019 Oct; 54 (10):2162-2165 Epub 2019 Jan ...

10. Comparing modalities for detecting dysplasia in patients with IBD - Mayo Clinic

    Drugs & Supplements · Healthy Lifestyle · Books ... Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD.